Table 1.

Clinical Characteristic of Patients

Study ID	Age at Enrollment	Visual Acuity* Baseline		Visual Acuity* Follow-up‡		Refraction†		Foveal Sensitivity Baseline (dB)		Foveal Sensitivity Follow-up (dB)‡		Mean Defect Baseline (dB)		Mean Defect Follow- up (dB)‡
		RE	LE	RE	LE	RE	LE	RE	LE	RE	LE	RE	LE	RE	LE
P1	30	20/20	20/20	20/20	20/20	Plano	Plano	34	34	38	38	−1.70	−1.44	+1.20	+1.02
P2	57	20/20	20/20	20/20	20/20	−0.25	+0.12	36	36	na	na	+1.40	+0.91	+1.61	+1.13
P3	52	20/20	20/20	20/20	20/20	+0.50	+0.50	na	na	na	na	−0.08	−0.59	−3.75	−3.54
P4	61	20/20	20/20	20/20	20/20	−6.25	−6.75	29	31	na	na	na	na	+2.16	+1.48
P5	60	20/20	20/20	20/20	20/20	+1.00	+1.00	37	37	32	34	+1.57	+1.37	+0.06	+0.10
P6	59	20/20	20/20	20/20	20/20	−1.00	Plano	na	na	34	32	+1.47	+0.84	+1.59	+1.31
P7	53	20/20	20/20	20/20	20/20	−0.25	Plano	33	33	35	34	−1.34	−2.32	−1.34	−1.68
P8	69	20/20	20/20	20/20	20/20	+0.25	+0.75	na	na	32	36	−0.04	+0.29	+0.88	+0.85
P9	65	20/40	20/20	20/25	20/20	+2.00	+2.00	na	na	31	33	−0.93	−0.71	−2.78	−1.57
P10§	68	20/20	20/25	20/20	20/25	+1.75	+2.00	35	28	38	30	−3.77	−23.59	+0.50	−17.07
P11	51	20/20	20/20	20/20	20/20	−0.25	+0.12	33	34	na	na	−0.52	−0.04	na	na

^*Best-corrected visual acuity.

^†Spherical equivalent.

^‡Follow-ups are at the 6-month visit (range 150–188 days) except P6 which was at the 1-month visit, before treatment discontinuation. Normal mean foveal sensitivity ± 2 SD = 38 ± 6 dB.

^§P10 carries a diagnosis of open-angle glaucoma with a dense arcuate visual field defect, both eyes.

LE, left eye; na, not available/not performed; RE, right eye.